|

Tocilizumab/Tocilizumab Biosimilar Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Kathy Miller1

Indications

  • ER-Positive HER2-Negative Breast Cancer1
  • Estrogen-receptor-low Breast Cancer1
  • Metastatic Breast Cancer1
  • Triple Negative Breast Cancer1
  • Breast Cancer1

Atlanta, Georgia1 trial

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

Emory University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.